beta
/Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)